This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignees: Drexel University, Imclone LLC. Active years: 2013.
Company Filing History:
1 out of 668 
1 out of 26 
Years Active: 2013
Title: Nathan Graeme Dolloff: Innovator in Bone Cancer Treatment
Introduction
Nathan Graeme Dolloff is an accomplished inventor based in Morgantown, PA (US). He has made significant contributions to the field of medical science, particularly in the treatment of bone cancer. His innovative approach focuses on utilizing antibodies to combat secondary bone tumors.
Latest Patents
Dolloff holds a patent for "Methods of treating secondary bone tumors with antibodies against PDGFR alpha." This invention provides methods for treating bone cancer, especially metastatic bone cancer, by administering a PDGFR alpha antagonist. The invention also outlines methods for treating a mammal with a neoplastic disease using the antibodies alone or in combination with other agents. He has 1 patent to his name.
Career Highlights
Throughout his career, Dolloff has worked with notable organizations such as Imclone LLC and Drexel University. His work in these institutions has allowed him to further his research and develop innovative solutions for complex medical challenges.
Collaborations
Dolloff has collaborated with esteemed colleagues, including Nick Loizos and Alessandro Fatatis. These partnerships have contributed to the advancement of his research and the successful development of his patented methods.
Conclusion
Nathan Graeme Dolloff is a pioneering inventor whose work in treating bone cancer has the potential to significantly impact the medical field. His innovative methods and collaborations highlight his dedication to advancing cancer treatment.